Canada PharmacyCanada Online Pharmacy reliable generic
€0.00 (0 items)Checkout

Categories list

Social bookmarks:

Our billing is certified by:

Secure shopping certificates

Special Offer!

Antivirals

Search by letter:

ABCDEFGHIJKLMNOPQRSTUVWXYZ
 
 
 
Famvir €2.36
Per pill
FamvirFamciclovir 250mg
Buy now!
Lamprene €2.17
Per pill
LampreneClofazimine 50mg
Buy now!
Rebetol €5.91
Per pill
RebetolRibavirin 200mg
Buy now!
Relenza €118.19
Per item
RelenzaZanamivir 5mg
Buy now!
Symmetrel €0.88
Per pill
SymmetrelAmantadine 100mg
Buy now!
Tamiflu €6.30
Per pill
TamifluOseltamivir 75mg
Buy now!
Valtrex €4.12
Per pill
ValtrexValacyclovir 0.5/1g
Buy now!
Zovirax €0.50
Per pill
ZoviraxAcyclovir 200/400/800mg
Buy now!
 
quicksearch
quicksearch

Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order. - Dave


Moneyback Guarantee
secure shopping
bookmark Bookmark this site
Subscribe to the News

Latest News

  • Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com

    Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody.

  • The Global Antivirals Market Expected To Reach $30 Billion By 2017 - OfficialWire (press release)

    The Global Antivirals Market Expected To Reach $30 Billion By 2017OfficialWire (press release)by Press Office In 2010, the global antivirals market was estimated to be worth $22.

  • deadly pandemic a matter of when, not if - Sydney Morning Herald

    deadly pandemic a matter of when, not ifSydney Morning HeraldThe drugs that would help are the antivirals, such as Relenza and Tamiflu.

  • Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition

    Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special Editionby Christina Frangou San Francisco—For several months, it has been one of the most pressing questions among clinicians who treat patients with hepatitis C: How well do the two FDA-approved direct-acting antivirals (DAAs) perform in the patients who .

  • New directions and challenges in viral hepatitis care and research - News-Medical.net

    New directions and challenges in viral hepatitis care and researchNews-Medical.